Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | PDK2 | Q15119 | 10/20 | 0.55 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | FABP4 | P15090 | 3/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL68561 | 1.00 | THRB (0.70) | THRBTDP1PDK2AKR1A1AKR1B1 | |
| SCHEMBL120476 | 0.91 | THRB (0.53) | THRBTDP1PDK2AKR1A1AKR1B1 | |
| SCHEMBL8539410 | 0.89 | THRB (0.55) | THRBTDP1PDK2AKR1A1AKR1B1 | |
| SCHEMBL30488775 | 0.84 | THRB (1.00) | THRBTDP1PDK2HSP90AA1 | |
| SCHEMBL11469925 | 0.84 | THRB (1.00) | THRBTDP1PDK2HSP90AA1 | |
| SCHEMBL66735 | 0.84 | THRB (1.00) | THRBTDP1PDK2HSP90AA1 | |
| SCHEMBL15449183 | 0.83 | PDK2 (0.51) | THRBTDP1PDK2AKR1A1AKR1B1 | |
| Bromide SCHEMBL27743796 | 0.82 | THRB (0.95) | THRBTDP1PDK2HSP90AA1 | |
| SCHEMBL8827312 | 0.81 | PDK2 (0.50) | THRBTDP1PDK2AKR1A1AKR1B1 | |
| SCHEMBL29359326 | 0.81 | PDK2 (0.50) | THRBTDP1PDK2AKR1A1AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240199600-A1 | CONDENSED HETEROCYCLIC COMPOUND HAVING A SULFONAMIDE GROUP OR SALT THEREOF, AGRICULTURAL OR HORTICULTURAL INSECTICIDE OR ANIMAL ECTOPARASITE OR ENDOPARASITE CONTROL AGENT COMPRISING THE COMPOUND OR THE SALT THEREOF, AND METHOD FOR USING THE COMPOUND OR THE SALT THEREOF, THE INSECTICIDE, OR THE CONTROL AGENT | NIHON NOHYAKU CO., LTD. (JP) | 2024-06-20 | — | — | US | disclosed |
| WO-2023154183-A1 | COMPOSITION INCLUDING EFFERVESCENT AGENTS, BIOSTIMULANT, NUTRIENT, AND PESTICIDE | ROBBINS JEFFREY (US) | 2023-08-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199600-A1 | CONDENSED HETEROCYCLIC COMPOUND HAVING A SULFONAMIDE GROUP OR SALT THEREOF, AGRICULTURAL OR HORTICULTURAL INSECTICIDE OR ANIMAL ECTOPARASITE OR ENDOPARASITE CONTROL AGENT COMPRISING THE COMPOUND OR THE SALT THEREOF, AND METHOD FOR USING THE COMPOUND OR THE SALT THEREOF, THE INSECTICIDE, OR THE CONTROL AGENT | HDAC2, HDAC1, HDAC11 | THRB 4614/4885TDP1 3592/4885PDK2 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.